Glycomics/Glycobiology Market Trends

  • Report ID: 2635
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Glycomics/Glycobiology Market Trends

Growth Drivers

Proliferating Cancer and Diabetic Diseases To Drive the Market Growth

Increment in diseases such as cancer and diabetes are the major factor fueling the market. According to the World Health Organization, one in every 5 men and one in every 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. Additionally, continuous technological advancements, rising research & development expenditure by pharmaceutical companies, rising funding through government bodies, and availability of products to conduct protocol with high specificity and sensitivity are anticipated to drive the market over the forecast period.

Restraints

High Production Cost Hindering the Global Market

The market is anticipated to be hindered by factors such as high production cost owing to the fluctuating prices of raw materials that are required for the manufacturing of glycomics/glycobiology, coupled with the low availability of skilled professionals that raises the overall operational expenses of the manufacturers operating in the market.

Glycomics/Glycobiology Market: Key Insights

Base Year

2023

Forecast Year

2024–2036

CAGR

13.2%

Base Year Market Size (2023)

USD 1.71 billion

Forecast Year Market Size (2036)

USD 8.57 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2635
  • Published Date: Oct 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of glycomics/glycobiology is estimated at USD 1.89 billion.

Glycomics/Glycobiology Market size was over USD 1.71 billion in 2022 and is anticipated to cross USD 8.57 billion by 2035, growing at more than 13.2% CAGR during the forecast period i.e., between 2024-2036.

North America industry is expected to hold largest revenue share by 2036, attributed to increasing investments in glycomics/glycobiology research, presence of all key players, along with the rising R&D investments in pharmaceutical companies for drug discovery.

The major players in the market are Merck KGaA, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, RayBiotech, New England Biolabs Inc., Bio-Techne Corporation, Chemily Glycoscience, Dextra Laboratories Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample